Koninklijke Philips N.V. (PHG)

NYQ – Real vaqt narxi. Valyuta: USD

27.01

+0.28 (1.05%)

Yopilishda: May 12, 2026, 4:00 PM EDT

25.94

-1.07 (-3.98%)

Bozor oldidan: May 13, 2026, 4:01 AM EDT

08.05.2026

Philips shareholders approve all proposals at the AGM 2026

May 8, 2026 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that its shareholders approved all proposals at the Annual General Meeting of Shareholders (AGM) 2026, including: Appointment of John DeFord (American, 1962) as new member of the Supervisory Board, with effect from May 8, 2026. Re-appointment of Paul Stoffels (Belgian, 1962), Herna Verhagen (Dutch, 1966) and Sanjay Poonen (American, 1969) as members of the Supervisory Board, with effect from May 8, 2026.

07.05.2026

Philips Q1 Earnings and Revenues Decrease Year over Year, Shares Up

PHG stock gains after Philips posts Q1 earnings, with 4% comparable sales growth and improved cash flow despite lower revenues.

06.05.2026

PHG Breakdown, Earnings Beat & AI Outlook

CEO of Philips, Roy Jakobs reviews strong earnings highlighting margin expansion despite inflation and a solid start to the year. He notes the company reiterated full-year guidance and remains focused on controlling what it can within earnings execution.

06.05.2026

Philips Reports Strong Order Intake Despite Uncertain Macro Environment

Koninklijke Philips N.V. (NYSE:PHG) shares were trading higher on Wednesday as the company reported strong order intake and comparable sales growth in its recent first quarter 2026 performance.

06.05.2026

Koninklijke Philips N.V. (PHG) Q1 2026 Earnings Call Transcript

06.05.2026

From jewelers to health tech, CEOs want tariff refunds as earnings take a hit

Philips and Pandora on Wednesday said they have applied for tariff reimbursement. Several other firms mentioned tariffs as negatively impacting results in a slew of earnings updates.

06.05.2026

Philips CEO: We will ask Trump administraton for tariff rebate

Philips CEO Roy Jakobs confirms the company will request a rebate on tariffs from the Trump administration, as the Dutch healthcare group says it's seen high growth in order intake, boosted by demand in North America.

Philips delivers strong order intake, comparable sales growth and margin expansion in Q1; 2026 outlook reiterated

May 6, 2026 Q1 2026 Group performance Comparable order intake growth 6% Group sales of EUR 3.9 billion, reflecting 4% increase in comparable sales Income from operations increased to EUR 241 million Adjusted EBITA margin increased 40 basis points to 9.0% Operating cash flow of EUR 188 million, with free cash flow of EUR 28 million 2026 outlook reiterated Roy Jakobs, CEO of Royal Philips: “We delivered a good start to 2026, with strong order intake growth at 6%, comparable sales growth of 4% and margin expansion of 40 basis points, reflecting disciplined execution against our plan in an uncertain macro-environment. Sales grew across segments and was led by North America and Europe.

23.04.2026

Philips launches new Bridge Plus Occlusion Balloon to help manage rare but life-threatening SVC tears during lead extraction

April 23, 2026 Bridge Plus was designed for rare, life-threatening emergencies to help control bleeding during superior vena cava (SVC) tears, which occur in

22.04.2026

Philips receives FDA 510(k) clearance for its Rembra platform, expanding access to faster, more precise CT imaging across frontline care and cancer treatment planning

April 22, 2026 Clearances for Rembra CT, Rembra RT, and Areta RT enable high-throughput imaging at scale and elevate precision across the cancer care pathway Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Rembra platform of scanning systems, including Rembra CT, Rembra RT and Areta RT. The newly cleared systems are designed to help healthcare providers respond to growing demand for imaging and radiation therapy planning by helping to improve speed, efficiency, and access to high-quality imaging.

Koninklijke Philips N.V. (PHG)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Koninklijke Philips N.V. (PHG)

Philips shareholders approve all proposals at the AGM 2026

Philips Q1 Earnings and Revenues Decrease Year over Year, Shares Up

PHG Breakdown, Earnings Beat & AI Outlook

Philips Reports Strong Order Intake Despite Uncertain Macro Environment

Koninklijke Philips N.V. (PHG) Q1 2026 Earnings Call Transcript

From jewelers to health tech, CEOs want tariff refunds as earnings take a hit

Philips CEO: We will ask Trump administraton for tariff rebate

Videolar

Press-relizlar

Philips shareholders approve all proposals at the AGM 2026

Philips delivers strong order intake, comparable sales growth and margin expansion in Q1; 2026 outlook reiterated

Philips launches new Bridge Plus Occlusion Balloon to help manage rare but life-threatening SVC tears during lead extraction

Philips receives FDA 510(k) clearance for its Rembra platform, expanding access to faster, more precise CT imaging across frontline care and cancer treatment planning

Philips shareholders approve all proposals at the AGM 2026

Philips Q1 Earnings and Revenues Decrease Year over Year, Shares Up

PHG Breakdown, Earnings Beat & AI Outlook

Philips Reports Strong Order Intake Despite Uncertain Macro Environment

Koninklijke Philips N.V. (PHG) Q1 2026 Earnings Call Transcript

From jewelers to health tech, CEOs want tariff refunds as earnings take a hit

Philips CEO: We will ask Trump administraton for tariff rebate

Videolar

Press-relizlar

Philips shareholders approve all proposals at the AGM 2026

Philips delivers strong order intake, comparable sales growth and margin expansion in Q1; 2026 outlook reiterated

Philips launches new Bridge Plus Occlusion Balloon to help manage rare but life-threatening SVC tears during lead extraction

Philips receives FDA 510(k) clearance for its Rembra platform, expanding access to faster, more precise CT imaging across frontline care and cancer treatment planning

Search stocks

Koninklijke Philips N.V. (PHG)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Koninklijke Philips N.V. (PHG)

Philips shareholders approve all proposals at the AGM 2026

Philips Q1 Earnings and Revenues Decrease Year over Year, Shares Up

PHG Breakdown, Earnings Beat & AI Outlook

Philips Reports Strong Order Intake Despite Uncertain Macro Environment

Koninklijke Philips N.V. (PHG) Q1 2026 Earnings Call Transcript

From jewelers to health tech, CEOs want tariff refunds as earnings take a hit

Philips CEO: We will ask Trump administraton for tariff rebate

Videolar

Press-relizlar

Philips shareholders approve all proposals at the AGM 2026

Philips delivers strong order intake, comparable sales growth and margin expansion in Q1; 2026 outlook reiterated

Philips launches new Bridge Plus Occlusion Balloon to help manage rare but life-threatening SVC tears during lead extraction

Philips receives FDA 510(k) clearance for its Rembra platform, expanding access to faster, more precise CT imaging across frontline care and cancer treatment planning

Philips shareholders approve all proposals at the AGM 2026

Philips Q1 Earnings and Revenues Decrease Year over Year, Shares Up

PHG Breakdown, Earnings Beat & AI Outlook

Philips Reports Strong Order Intake Despite Uncertain Macro Environment

Koninklijke Philips N.V. (PHG) Q1 2026 Earnings Call Transcript

From jewelers to health tech, CEOs want tariff refunds as earnings take a hit

Philips CEO: We will ask Trump administraton for tariff rebate

Videolar

Press-relizlar

Philips shareholders approve all proposals at the AGM 2026

Philips delivers strong order intake, comparable sales growth and margin expansion in Q1; 2026 outlook reiterated

Philips launches new Bridge Plus Occlusion Balloon to help manage rare but life-threatening SVC tears during lead extraction

Philips receives FDA 510(k) clearance for its Rembra platform, expanding access to faster, more precise CT imaging across frontline care and cancer treatment planning